AADI - Aadi Bioscience, Inc.
Aadi Bioscience, Inc.
17383 Sunset Boulevard
Suite A250
Pacific Palisades, CA 90272
United States
424 473 8055
https://aadibio.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 80
Key executives
| Name | Title | Pay | Exercised | Year born |
|---|---|---|---|---|
| Dr. Neil P. Desai Ph.D. | Founder, Sec. & Exec. Chairman | 1.12M | N/A | 1965 |
| Dr. Loretta M. Itri F.A.C.P., M.D. | Chief Medical Officer | 805.85k | N/A | 1950 |
| Mr. Scott M. Giacobello CPA | Interim CEO, Pres, CFO & Treasurer | N/A | N/A | 1970 |
| Ms. Marcy Graham | SVP of Investor Relations & Corp. Communications | N/A | N/A | 1967 |
| Mr. Stephen M. Rodin J.D. | Sr. VP of Legal & Gen. Counsel | N/A | N/A | 1976 |
| Mr. Raymond G. Steitz | Sr. VP of HR & Chief HR Officer | N/A | N/A | 1959 |
| Mr. Bryan Ball | Chief Quality Officer & Sr. VP of Manufacturing Operations | N/A | N/A | 1970 |
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus bound to albumin. The company is also involved in evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Corporate governance
Aadi Bioscience, Inc.’s ISS governance QualityScore as of 1 June 2023 is 8. The pillar scores are Audit: 8; Board: 7; Shareholder rights: 8; Compensation: 9.
